Showing results (11-20 of 424) with videos related to

Sort By:
Pageof 43
Current Opinion in Nephrology and Hypertension|April 15, 2008
Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolismAgnes B Fogo
Nature Reviews. Nephrology|December 3, 2014
Causes and pathogenesis of focal segmental glomerulosclerosisAgnes B Fogo
The Journal of Clinical Investigation|August 5, 2003
Renal fibrosis: not just PAI-1 in the skyAgnes B Fogo
Kidney International|October 24, 2021
Gains in understanding of podocyte lossAgnes B Fogo
Kidney International. Supplement|July 17, 2003
Hypertensive risk factors in kidney disease in African AmericansAgnes B Fogo
The Journal of Clinical Investigation|May 25, 2011
The targeted podocyteAgnes B Fogo
Pediatric Nephrology (Berlin, Germany)|July 25, 2007
Mechanisms of progression of chronic kidney diseaseAgnes B Fogo
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 11, 2023
Low-Dose Erythropoietin Amplifies Beneficial Effects of Angiotensin II Blockade on GlomerulosclerosisJiayi Wang, Keizo Matsushita, Jianyong Zhong, et al.
Journal of the American Society of Nephrology : JASN|October 4, 2011
Cells derived from young bone marrow alleviate renal agingHai-Chun Yang, Michele Rossini, Li-Jun Ma, et al.
Journal of the American Society of Nephrology : JASN|October 3, 2009
The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injuryHai-Chun Yang, Sebastien Deleuze, Yiqin Zuo, et al.
Pageof 43